Garland C J, Plane F, Kemp B K, Cocks T M
Department of Pharmacology, University of Bristol, UK.
Trends Pharmacol Sci. 1995 Jan;16(1):23-30. doi: 10.1016/s0165-6147(00)88969-5.
Endothelial-dependent relaxation of vascular smooth muscle cells evoked by a number of agonists, including cholinomimetics and substance P, is often accompanied by an increase (repolarization and/or hyperpolarization) in the membrane potential. This change in membrane potential appears predominantly to reflect the action of an endothelial-derived hyperpolarizing factor (EDHF), which is distinct from NO (or endothelial-derived relaxing factor), and is discussed in this article by Chris Garland and colleagues. In large conducting arteries, EDHF may provide a secondary system to NO, which assumes primary importance in some disease states such as pulmonary hypertension and atherosclerosis. However, in small resistance arteries (100-300 microns), EDHF appears to be a major determinant of vascular calibre under normal conditions, and may therefore be of primary importance in the regulation of vascular resistance.
多种激动剂(包括拟胆碱药和P物质)引起的血管平滑肌细胞的内皮依赖性舒张,常伴随着膜电位的升高(复极化和/或超极化)。膜电位的这种变化主要似乎反映了一种内皮源性超极化因子(EDHF)的作用,它不同于一氧化氮(或内皮源性舒张因子),克里斯·加兰及其同事在本文中对此进行了讨论。在大的传导动脉中,EDHF可能是一氧化氮的次要系统,而一氧化氮在某些疾病状态(如肺动脉高压和动脉粥样硬化)中起主要作用。然而,在小的阻力动脉(100 - 300微米)中,在正常情况下EDHF似乎是血管口径的主要决定因素,因此可能在血管阻力调节中起主要作用。